Quality of life in black African patients with keloid scars.

Dermatol Reports

Department of dermatology and venerology, Training and research units of medical sciences, University of Felix Houphouet-Boigny of Abidjan, Côte d'Ivoire.

Published: September 2020

A keloid scar is a benign skin tumor and we aimed to assess the Quality of Life (QoL) of black Africans with keloid scars based on the Dermatology Life Quality Index (DLQI). We conducted a cross-sectional descriptive study in the department of dermatology of the teaching hospital of Treichville in Ivory Coast. We recruited 132 patients with keloid and 3612 dermatoses without keloid: The prevalence was 3.50% (132/3753). We included 120 patients aged from 16 to 63 years old, the sex ratio was 0.46 (38/82) and the mean age was 34.20 years. Keloid scars were mostly secondary to skin trauma in 30.00 % and infection in 21.67%. The commonest site was the ear in 29.17 %. We reported Keloid with pain in 53.33% and pruritus in 95.00%. We observed psychological impact in 65.83%. The DLQI scores were moderate and high in 61.66 %. QoL was impacted significantly when keloid was associated with pain (p=0.046), pruritus (p=0.81) and functional disorders (p=0.29). The DLQI score could be a valuable tool to assess QoL in black African patients with keloid, for better treatment option.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772769PMC
http://dx.doi.org/10.4081/dr.2020.8312DOI Listing

Publication Analysis

Top Keywords

patients keloid
12
keloid scars
12
keloid
9
quality life
8
black african
8
african patients
8
qol black
8
life black
4
patients
4
scars keloid
4

Similar Publications

The ethics behind treating scars in skin of color research subjects.

J Am Acad Dermatol

December 2024

The Henry W. Lim, MD, Division of Photobiology and Photomedicine, Henry Ford Health, Department of Dermatology, 3031 W Grand Blvd, 8th Floor, Detroit, Michigan 48202.

View Article and Find Full Text PDF

 To evaluate the possibility of improving and preventing the formation of postoperative hypertrophic and keloid scars using botulinum toxin type A (BTA).  Scientific articles published in English have been systematically screened in PubMed/MEDLINE database over the entire period. The following information about the studies was analyzed: first author surname; year of publication; number of patients; average age; scar location; dosage of the drug administered; follow-up duration; scar assessment methods; results, incidence of hypertrophic and keloid scars formation.

View Article and Find Full Text PDF

Bridging the Gap in Acne Vulgaris Research for Skin of Color Patients.

J Am Acad Dermatol

December 2024

Department of Dermatology, Weill Cornell Medicine, New York, NY, USA. Electronic address:

View Article and Find Full Text PDF

The Surgical Repair of an Avulsion Dog Bite and Scar Revision in Highly Melanated Skin: A Case Report.

Cureus

November 2024

Plastic and Reconstructive Surgery, Middletown Aesthetics and Plastic Surgery, Middletown, USA.

Dog bites are one of the most common injuries in the United States, with varying presentations such as avulsion injuries and lacerations, and they range from a single bite to multiple bites in a victim. The severity of the dog bite is often the biggest factor in determining the treatment course. This report discusses the treatment of a 60-year-old male with severe facial avulsion trauma from a dog bite.

View Article and Find Full Text PDF

Ablative fractional laser-assisted drug delivery has gained attention as a promising method for enhancing dermal drug absorption and improving therapeutic outcomes in dermatological conditions, particularly for hypertrophic and keloid scars. However, despite the growing number of clinical trials and case reports supporting its efficacy, there remains a scarcity of robust evidence on the topical bioavailability and dermato-pharmacokinetics of drugs in human subjects. This study aimed to examine the enhancement of triamcinolone acetonide (TAC) bioavailability following treatment with a fractional Erbium-Doped Yttrium Aluminum Garnet (Er: YAG) laser.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!